Wilate

Wilate is a human coagulation factor VIII and von Willebrand factor concentrate used to manage bleeding disorders. It supports clotting and is administered intravenously. Suitable for hemophilia A and von Willebrand disease. Trusted for reliable clotting support.

Wilate is used to treat and prevent bleeding episodes in patients with hemophilia A, a condition where blood lacks sufficient clotting factor VIII. It is also prescribed for von Willebrand disease, a bleeding disorder caused by a deficiency in von Willebrand factor. This medication helps restore clotting function and reduce bleeding risk. It may be used before medical procedures to prevent excessive bleeding.

After administration, Wilate works by increasing levels of clotting factors in the blood, supporting the body's natural clotting process. Users may notice reduced bleeding episodes and improved clotting function. The effects vary by individual and depend on the condition being treated. Regular use may help maintain stable clotting levels.

Wilate should be stored properly to maintain its effectiveness. Keep it refrigerated but avoid freezing. Always check the expiration date before use. Use only as prescribed by a healthcare professional. Inform your doctor of any allergies or reactions to blood products. Follow all handling and administration instructions carefully.

Wilate may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Avoid combining it with treatments that could increase bleeding risk. Alcohol and certain herbal supplements may also interact. Always inform your healthcare provider about all medications and supplements you are taking.